Check Out 3 High-Yielding Dividend Stocks In Real Estate Sector From Wall Street's Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Uniti Group Inc. UNIT

• Dividend Yield: 12.74%
• Morgan Stanley analyst Simon Flannery maintained an Underweight rating and cut the price target from $7 to $6 on June 1, 2023. This analyst has an accuracy rate of 71%.
• Citigroup analyst Michael Rollins maintained a Neutral rating and lowered the price target from $9 to $7.25 on Feb. 1, 2023. This analyst has an accuracy rate of 77%.
• Recent News: Uniti Group filed for mixed-securities shelf offering.

Office Properties Income Trust OPI

• Dividend Yield: 12.66%
• Morgan Stanley analyst Ronald Kamdem maintained an Underweight rating and cut the price target from $11 to $5 on May 30, 2023. This analyst has an accuracy rate of 61%.
• B. Riley Securities analyst Bryan Maher maintained a Buy rating and slashed the price target from $29 to $27 on Feb. 21, 2023. This analyst has an accuracy rate of 66%.
• Recent News: Office Props IT reported a decline in first-quarter sales.

Medical Properties Trust, Inc. MPW

• Dividend Yield: 12.75%
• Truist Securities analyst Michael Lapides maintained a Hold rating and raised the price target from $8 to $9 on March 31, 2023. This analyst has an accuracy rate of 63%.
• Raymond James analyst Jonathan Hughes maintained a Strong Buy rating and cut the price target from $18 to $16 on March 2, 2023. This analyst has an accuracy rate of 64%.
• Recent News: Medical Properties Trust reported first-quarter revenues of $350.2 million, missing the consensus of $354.6 million.

Read More: Investor Sentiment Improves Further Following Inflation Report